taxonomy (2)
protein (6)
source (3)
structure (0)
composition (1)
disease (2)
reference (3)
site (18)
peptide (27)
- Alpha-2-HS-glycoprotein / Homo sapiens P02765
- CD59 glycoprotein / Homo sapiens P13987
- Interstitial collagenase / Homo sapiens P03956
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Uromodulin / Homo sapiens P07911
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- HEK293 (CVCL_0045)
Source
Reported structure
- Hex:7 HexNAc:4 dHex:2 (avg mass : 2258.0781 )
Composition
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
Reference
- Alpha-2-HS-glycoprotein / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Interstitial collagenase / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Uromodulin / Homo sapiens
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- TAVNCSSDFDACLITK (16aa)
- WFSAGLASNSSWLR (14aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYF (48aa)
- FFSNVTWFHAIHVSGTNGTKR (21aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEK (53aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- SNIIRGWIFGTTLDSKTQSLLIVNNATNVVIK (32aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGK (35aa)
- NDPFLGVYYHKNNKSWMESEFR (22aa)
- VCEFQFCNDPFLGVYYHKNNKSWMESEFR (29aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLMD (31aa)
- LGVYYHKNNK (10aa)
- VYSSANNCTFEYVSQPF (17aa)
- AALAAFNAQNNGSNFQLEEISR (22aa)
- FPNITNLCPFGEVFNAT (17aa)
- GEVFNATRFASVYAWNR (17aa)
- FALLMTNCYATPSSNATDPLK (21aa)
- VYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGA (34aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMT (41aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDK (63aa)
- AICHDGKAHFPREGVFVSNGTHWFVTQR (28aa)
- NFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKY (48aa)
- NFYEPQIITTDNTFVSGNCDVVIGIVNNTV (30aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- NHTSPDVDLGDISGINASV (19aa)
- LNEVAKNLNESLI (13aa)
- NLNESLIDLQELGK (14aa)
Mass spectrometry observed peptide
-
- Hex:7 HexNAc:4 dHex:2 / N-Linked (avg mass : 2258.0781)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- HEK293 (CVCL_0045)
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Alpha-2-HS-glycoprotein / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Interstitial collagenase / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Uromodulin / Homo sapiens
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TAVNCSSDFDACLITK (16aa)
- WFSAGLASNSSWLR (14aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYF (48aa)
- FFSNVTWFHAIHVSGTNGTKR (21aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEK (53aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- SNIIRGWIFGTTLDSKTQSLLIVNNATNVVIK (32aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGK (35aa)
- NDPFLGVYYHKNNKSWMESEFR (22aa)
- VCEFQFCNDPFLGVYYHKNNKSWMESEFR (29aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLMD (31aa)
- LGVYYHKNNK (10aa)
- VYSSANNCTFEYVSQPF (17aa)
- AALAAFNAQNNGSNFQLEEISR (22aa)
- FPNITNLCPFGEVFNAT (17aa)
- GEVFNATRFASVYAWNR (17aa)
- FALLMTNCYATPSSNATDPLK (21aa)
- VYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGA (34aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMT (41aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDK (63aa)
- AICHDGKAHFPREGVFVSNGTHWFVTQR (28aa)
- NFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKY (48aa)
- NFYEPQIITTDNTFVSGNCDVVIGIVNNTV (30aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- NHTSPDVDLGDISGINASV (19aa)
- LNEVAKNLNESLI (13aa)
- NLNESLIDLQELGK (14aa)
Source
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
